Advertisements


Provention CEO says creating new pharmaceutical category for autoimmunity

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 11th, 2018

Takeda closes $62B purchase of Shire, creating largest Mass. biotech employer

Takeda Pharmaceutical Co. Ltd. and Shire plc finalized their record-setting tie-up Monday, creating what will likely be Massachusetts' largest life science employer and one of the world's largest drug companies. The Japanese drugmaker announced la.....»»

Category: topSource: bizjournalsJan 7th, 2019

Bristol-Myers bulks up with $74 billion deal to buy Celgene

Bristol-Myers Squibb Co said on Thursday it would buy Celgene Corp for about $74 billion, creating one of the biggest pharmaceutical companies and combining two significant cancer drug businesses......»»

Category: topSource: reutersJan 3rd, 2019

San Francisco sues McKesson and others for fueling opioid crisis

San Francisco City Attorney Dennis Herrera filed a lawsuit Tuesday in federal court suing McKesson and other pharmaceutical companies for their alleged role in creating the nation's current opioid crisis. The suit broadly alleges that the defendant.....»»

Category: topSource: bizjournalsDec 19th, 2018

Takeda clears key hurdle as investors back $59 billion Shire deal

Takeda Pharmaceutical has won shareholder approval for its $59 billion takeover of London-listed Shire , creating a global powerhouse that has a stronger drugs pipeline but is also saddled with massive debt......»»

Category: topSource: reutersDec 5th, 2018

$59bln: What it costs to become a drugs player

Takeda Pharmaceutical shareholders approved on Wednesday its $59 billion takeover of London-listed Shire, creating a global powerhouse with a stronger drugs pipeline but one that is saddled with massive debt. Julian Satterthwaite reports......»»

Category: videoSource: reutersDec 5th, 2018

Takeda investors back $59 billion Shire deal, but wary of debt load

Takeda Pharmaceutical shareholders approved on Wednesday its $59 billion takeover of London-listed Shire , creating a global powerhouse with a stronger drugs pipeline but one that is saddled with massive debt......»»

Category: topSource: reutersDec 5th, 2018

Takeda shareholders give nod for $59 billion Shire acquisition

Takeda Pharmaceutical shareholders approved on Wednesday its $59 billion takeover of London-listed Shire , creating a global powerhouse with a stronger drugs pipeline but one that is saddled with massive debt......»»

Category: topSource: reutersDec 4th, 2018

Takeda shareholders approve Shire acquisition: spokesman

Takeda Pharmaceutical shareholders approved on Wednesday its $59 billion takeover of London-listed Shire , a Takeda spokesman said, creating a global powerhouse with a stronger drugs pipeline but one that is saddled with massive debt......»»

Category: topSource: reutersDec 4th, 2018

Oscars to Add ‘Popular Film’ Category, Creating Questions

By adding a new category, the Academy Awards risk signaling that blockbuster films are not worthy of consideration for the best overall picture honor......»»

Category: mediaSource: nytAug 8th, 2018

JP Morgan to launch first bank-backed cryptocurrency

JP Morgan is creating its own cryptocurrency, and is becoming the first major U.S. bank to do so......»»

Category: topSource: moneycentral11 hr. 29 min. ago

Ed Goldman: Creating her own organizational culture at new California lawyers group

“I think the best thing about heading up a new organization is you get to create its culture from the ground up,” says Ona Alston Dosunmu. She’s the first full-time executive director of the 1-year-old California Lawyers Association — a trad.....»»

Category: topSource: bizjournals11 hr. 59 min. ago

Check out La Cocina and the Bay Area"s other incubators for food, robots, clean energy and more

Not all incubators and accelerators are pumping out the next big app. Here are some that are creating restaurants, robots, and clean energy solutions.  All the organizations ranked on the San Francisco Business Times' Greater Bay Area Accelerato.....»»

Category: topSource: bizjournalsFeb 15th, 2019

After strong 2019 start for U.S. stocks, trade verdict looms

Optimism about a U.S.-China trade agreement has helped drive U.S. stocks to more than two-month highs, creating a make-or-break moment for Wall Street as a year-long clash between the world's two largest economies comes to a head......»»

Category: topSource: reutersFeb 15th, 2019

FLS Acquires Scott Logistics, Creating A $500M Revenue Brokerage

The largest Ca.....»»

Category: blogSource: benzingaFeb 15th, 2019

Digital Brands Are Booming. But Can They Save Malls?

Developers are creating a new breed of pop-up retail for online upstarts to experiment in brick and mortar. .....»»

Category: topSource: washpostFeb 15th, 2019

Cover Story: Entrepreneur Live panel — guides for the path to success

KCBJ gathered four veteran business owners for its Entrepreneur Live panel, and they shared their insights on creating and building businesses......»»

Category: topSource: bizjournalsFeb 15th, 2019

West Pharmaceutical Services Inc. 2018 Q4 - Results - Earnings Call Slides

West Pharmaceutical Services Inc. 2018 Q4 - Results - Earnings Call Slides.....»»

Category: topSource: seekingalphaFeb 14th, 2019

West Pharmaceutical Services" (WST) CEO Eric Green on Q4 2018 Results - Earnings Call Transcript

West Pharmaceutical Services" (WST) CEO Eric Green on Q4 2018 Results - Earnings Call Transcript.....»»

Category: topSource: seekingalphaFeb 14th, 2019

Wyden files 3 bills to shed light on rising drug prices and rebates and cap costs

U.S. Sen. Ron Wyden released a trifecta of drug pricing bills on Wednesday that he says will “bring transparency to the opaque, broken drug pricing system.” The three bills are: The Stopping the Pharmaceutical Industry from Keeping Drugs Expe.....»»

Category: topSource: bizjournalsFeb 14th, 2019

Teva Pharmaceutical stock price target cut to $15 from $18 at SVB Leerink

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchFeb 14th, 2019